Penn Blood Disorder Center
Philadelphia, Pennsylvania, United States
Hospital department in Philadelphia, Pennsylvania
3400 Civic Center Boulevard South Pavilion, 1st Floor, Philadelphia, PA 19104
About Penn Blood Disorder Center
"CORONAVIRUS INFO: Penn Medicine is dedicated to the health and safety of patients, their families, and our staff. Please visit our website for COVID-19 updates, including coronavirus FAQs, our visitation policy, and drive-thru testing."
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Pfizer
2
Clinical Trials at Penn Blood Disorder Center
During the past decade, Penn Blood Disorder Center conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study to Evaluate Prospective Efficacy and Safety Data of Current FIX Prophylaxis Replacement Therapy in Adult Hemophilia B Subjects (FIX:C≤2%) or Current FVIII Prophylaxis Replacement Therapy in Adult Hemophilia A Subjects (FVIII:C≤1%)
2018-07-26
2024-03-29
Recruiting
250
A Study to Evaluate the Efficacy and Safety of Factor IX Gene Therapy With PF-06838435 in Adult Males With Moderately Severe to Severe Hemophilia B
2019-07-29
2029-12-18
Recruiting
55
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Penn Blood Disorder Center
According to Clinical.Site data, the most researched conditions in "Penn Blood Disorder Center" are
"Hemophilia B" (2 trials) and "Hemophilia A" (1 trials). Many other conditions were trialed in "Penn Blood Disorder Center" in a lesser frequency.
Clinical Trials Intervention Types at Penn Blood Disorder Center
Most popular intervention types in "Penn Blood Disorder Center" are "Biological" (1 trials) and "Drug" (1 trials). Other intervention types were less common.
The name of intervention was led by "PF-06838435/ fidanacogene elaparvovec" (1 trials), "Standard of Care FIX Replacement therapy" (1 trials) and "Standard of Care FVIII Replacement therapy" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Penn Blood Disorder Center
The vast majority of trials in "Penn Blood Disorder Center" are
2 trials for "Male" genders.
Clinical Trials Status at Penn Blood Disorder Center
Currently, there are NaN active trials in "Penn Blood Disorder Center".
undefined are not yet recruiting,
2 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in Penn Blood Disorder Center,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Penn Blood Disorder Center, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".